Protein kinase C modulates telomerase activity in human cervical cancer cells.
- Author:
Yong Wook KIM
1
;
Soo Young HUR
;
Tae Eung KIM
;
Joon Mo LEE
;
Sung Eun NAMKOONG
;
In Kyung KI
;
Jin Woo KIM
Author Information
1. Department of Obstetrics and Gynecology, Kangnam St Mary's Hospital, Seoul, Korea.
- Publication Type:Original Article ; Research Support, Non-U.S. Gov't
- Keywords:
Cervical cancer;
PKC;
telomerase;
hTERT;
hTR
- MeSH:
Alternative Splicing;
Carbazoles/pharmacology;
Catalytic Domain;
Cervix Neoplasms/*enzymology;
Enzyme Inhibitors/metabolism;
Female;
Hela Cells;
Human;
Indoles/pharmacology;
Maleimides/pharmacology;
Protein Kinase C/antagonists & inhibitors/*metabolism;
RNA, Messenger/metabolism;
Support, Non-U.S. Gov't;
Telomerase/antagonists & inhibitors/genetics/*metabolism;
Tetradecanoylphorbol Acetate/pharmacology;
Tumor Cells, Cultured
- From:Experimental & Molecular Medicine
2001;33(3):156-163
- CountryRepublic of Korea
- Language:English
-
Abstract:
Telomerase, a ribonucleoprotein reverse transcriptase that extends telomeres of eukaryotic chromosomes is repressed in normal somatic cells but is activated during development and neoplasia. The regulation mechanism of telomerase activity in cancer cells is not clearly known. In this report, a possible affect of PKC on telomerase activity was examined using HeLa and CUMC-6 cervical cancer cell lines. Exposure of cells to PKC inhibitor, bisindolylmaleimide I and Go6976, and high levels of PKC activator, 12-O-tetradecanoyl phorbol 13-acetate (TPA) resulted in the inhibition of PKC activity in both cells. Telomerase activities were also inhibited by bisindolyl-maleimide I and Go6976, respectively, in a time-dependent manner. As PKC activity changes in TPA-treated cervical cancer cells, telomerase activities were increased at low dose of TPA and decreased at high dose. The expression levels of human telomerase subunits, human telomerase RNA (hTR) were not influenced by PKC modulating drugs. In contrast, the expression of full-length human telomerase reverse transcriptase (hTERT) was decreased after exposure to bisindolylmaleimide I and Go6976 in a time-dependent manner. hTERT expression was not affected by low dose of TPA. In contrast, high dose of TPA inhibited hTERT expression level. But the expression patterns of beta-deletion transcript of hTERT after 72 h of treatment with PKC inhibitors or high dose of TPA exposure were not discernable as compared with those of full-length hTERT transcripts to PKC modulating drugs. These results suggest that PKC-modulating drugs altered telomerase activities by affecting full-length hTERT expression profile in human cervical cancers.
